title: Some endocrine traits of transgenic rabbits. II. Changes in hormone secretion and response of isolated ovarian tissue to FSH and ghrelin.
abstract: In the present in vitro experiments we examined FSH- and ghrelin-induced changes in ovarian hormone secretion by transgenic rabbits. Fragments of ovaries isolated from adult transgenic (carrying mammary gland-specific mWAP-hFVIII gene) and non-transgenic rabbits from the same litter were cultured with and without FSH or ghrelin (both at 0, 1, 10 or 100 ng/ml medium). The secretion of progesterone (P4), estradiol (E2) and insulin-like growth factor I (IGF-I) was assessed by RIA. It was observed that ovaries isolated from transgenic rabbits secreted much less P4, E2 and IGF-I than the ovaries of non-transgenic animals. In control animals FSH reduced E2 (at doses 1-100 ng/ml medium) and IGF-I (at 1-100 ng/ml), but not P4 secretion, whereas ghrelin promoted P4 (at 1 ng/ml) and IGF-I (at 100 ng/ml), but not E2 output. In transgenic animals, the effects were reversed: FSH had a stimulatory effect on E2 (at 100 ng/ml) and ghrelin had an inhibitory effect on P4 (at 10 ng/ml). No differences in the pattern of influence of FSH on P4 and IGF-I and of ghrelin on E2 and IGF-I were found between control and transgenic animals. The present observations suggest that 1) both FSH and ghrelin are involved in rabbit ovarian hormone secretion, 2) transgenesis in rabbits is associated with a reduction in ovarian secretory activity, and 3) transgenesis can affect the response of ovarian cells to hormonal regulators.
authors.affiliation: Research Institute of Animal Production, Slovak Agricultural Research Centre, Nitra, Slovakia. sirotkin@scpv.sk
authors.forename: A V
authors.initials: AV
authors.lastname: Sirotkin
authors.forename: P
authors.initials: P
authors.lastname: Chrenek
authors.forename: K
authors.initials: K
authors.lastname: Darlak
authors.forename: F
authors.initials: F
authors.lastname: Valenzuela
authors.forename: Z
authors.initials: Z
authors.lastname: Kuklová
mesh_terms: D000818:Animals; D030801:Animals, Genetically Modified / Q000235:genetics / Q000378:metabolism*; D017209:Apoptosis; D049109:Cell Proliferation; D004958:Estradiol / Q000378:metabolism; D005169:Factor VIII / Q000235:genetics / Q000378:metabolism*; D005260:Female; D005640:Follicle Stimulating Hormone / Q000378:metabolism*; D054439:Ghrelin / Q000378:metabolism*; D006728:Hormones / Q000378:metabolism*; D007334:Insulin-Like Growth Factor I / Q000378:metabolism; D008894:Milk Proteins / Q000235:genetics*; D010053:Ovary / Q000378:metabolism*; D011374:Progesterone / Q000378:metabolism; D011401:Promoter Regions, Genetic; D011817:Rabbits; D011994:Recombinant Proteins / Q000378:metabolism; D013552:Swine; D046509:Tissue Culture Techniques
chemical_list: C515349:GHRL protein, human; D054439:Ghrelin; D006728:Hormones; D008894:Milk Proteins; D011994:Recombinant Proteins; C024471:whey acidic proteins; D011374:Progesterone; D004958:Estradiol; D007334:Insulin-Like Growth Factor I; D005169:Factor VIII; D005640:Follicle Stimulating Hormone